医药中间体是指在药物合成过程中作为关键步骤的反应产物或原料物质,它们通常是化学结构较为简单的化合物,通过一系列化学反应可以转化为最终的药物成品。这些中间体在制药工业中扮演着重要角色,是实现复杂药物分子合成的关键组成部分。
特点医药中间体的研发和生产是一个复杂的过程,通常包括以下几个步骤:
随着化学合成技术的进步和新技术的应用(如绿色化学、计算机辅助设计等),医药中间体的研发与生产正朝着更加高效、环保的方向发展。同时,对药物分子结构的深入理解也为开发更有效的治疗方案提供了更多可能性。
中文名称 | 英文名称 | CAS号 | 化学式 | 结构式图片 |
---|---|---|---|---|
(R)-2-丙基辛酸 | (R)-(-)-arundic acid | 185517-21-9 | C11H22O2 |
|
(R)-2-[1-(3-乙氧基-4-甲氧基苯基)-2-甲磺酰基乙基]-4-乙酰基氨基异吲哚啉-1,3-二酮 | (R)-N-(2-( 1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl)-1,3-dioxoisoindolin-4-yl)acetamide | 608141-44-2 | C22H24N2O7S |
|
(R)-2-[(5-溴-1H-吲哚-3-基)羰基]-1-吡咯烷甲酸苄酯 | (R)-3-[(N-benzyloxycarbonylpyrrolidin-2-yl)carbonyl]-5-bromo-1H-indole | 143322-56-9 | C21H19BrN2O3 |
|
(R)-2-(氨甲基)-1-BOC-吡咯烷 | tert-butyl (2R)-2-(aminomethyl)pyrrolidine-1-carboxylate | 259537-92-3 | C10H20N2O2 |
|
(R)-2-(Boc-氨甲基)吗啉 | tert-butyl N-[[(2R)-morpholin-2-yl]methyl]carbamate | 186202-57-3 | C10H20N2O3 |
|
(R)-2-(4-氯-2-甲基苯氧基)丙酸辛酯 | (R)-2-(4-chloro-2-methylphenoxy)propionic acid octyl ester | 66423-13-0 | C18H27ClO3 |
|
(R)-2-(3-氟苯基)吡咯烷盐酸盐 | (R)-2-(3-fluorophenyl)pyrrolidine hydrochloride | 1364890-61-8 | C10H12FN*ClH |
|
(R)-2-(2-氯苯基)吡咯烷 | (R)-2-(2-chlorophenyl)pyrrolidine | 823188-58-5 | C10H12ClN |
|
(R)-2-(1-羟乙基)吡啶 | (R)-1-(2'-pyridyl)ethanol | 27911-63-3 | C7H9NO |
|
(R)-2-((S)-2,2-二-5-OXO-1,3-二氧戊环-4-YL)-3-(萘-2-基)丙酸 | (R)-2-((S)-2,2-dimethyl-5-oxo-1,3-dioxolan-4-yl)-3-(naphthalen-2-yl)propanoic acid | 198568-07-9 | C18H18O5 |
|
(R)-2,5-二氢-3,6-二甲氧基-2-异丙基吡嗪 | (2R)-2,5-dihydro-2-isopropyl-3,6-dimethoxypyrazine | 109838-85-9 | C9H16N2O2 |
|
(R)-2,5-二氢-3,6-二乙氧基-2-异丙基吡嗪 | (2R)-3,6-diethoxy-2-isopropyl-2,5-dihydropyrazine | 110117-71-0 | C11H20N2O2 |
|
(R)-2,4-二氯-ALPHA-甲基-苯甲胺 | (R)-2,4-dichloro-α-methylbenzylamine | 133773-29-2 | C8H9Cl2N |
|
(R)-1-苯基-1,2,3,4-四氢异喹啉 | (R)-(-)-1-phenyl-1,2,3,4-tetrahydroisoquinoline | 180272-45-1 | C15H15N |
|
(R)-1-氨基丙烷-2-氨基甲酸苄酯 | (R)-benzyl 1-aminopropan-2-ylcarbamate | 346669-50-9 | C11H16N2O2 |
|
(R)-1-叔丁氧羰基-3-乙基哌嗪 | tert-butyl (R)-3-ethylpiperazine-1-carboxylate | 438050-08-9 | C11H22N2O2 |
|
(R)-1-叔丁氧羰基-3-(氨基甲基)吡咯烷 | tert-butyl 3-(aminomethyl)pyrrolidine-1-carboxylate | 270912-72-6 | C10H20N2O2 |
|
(R)-1-叔丁氧羰基-2-乙基哌嗪 | tert-butyl (R)-2-ethylpiperazine-1-carboxylate | 393781-70-9 | C11H22N2O2 |
|
(R)-1-z-2-叔丁基-3-甲基-4-咪唑啉酮 | (R)-2-t-butyl-1-carbobenzyloxy-3-methyl-4-imidazolidinone | 119906-46-6 | C16H22N2O3 |
|
(R)-1-n-boc-4-n-boc-哌嗪-2-羧酸 | (R)-1,4-bis(tert-butoxycarbonyl)piperazine-2-carboxylic acid | 173774-48-6 | C15H26N2O6 |
|
(R)-1-N-叔丁氧羰基哌嗪-3-甲酸甲酯 | 1-(tert-butyl) 3-methyl (R)-piperazine-1,3-dicarboxylate | 438631-77-7 | C11H20N2O4 |
|
(R)-1-N-CBZ-2-甲基-哌嗪盐酸盐 | (R)-benzyl 2-methylpiperazine-1-carboxylate hydrochloride | 1217848-48-0 | C13H18N2O2*ClH |
|
(R)-1-N-Boc-2-甲基哌嗪 | (R)-tert-butyl 2-methylpiperazine-1-carboxylate | 170033-47-3 | C10H20N2O2 |
|
(R)-1-Boc-3-羟基哌啶 | tert-butyl (3R)-3-hydroxypiperidine-1-carboxylate | 143900-43-0 | C10H19NO3 |
|
(R)-1-Boc-3-羟基吡咯烷 | (R)-N-tert-butyloxycarbonyl-3-pyrrolidinol | 109431-87-0 | C9H17NO3 |
|
(R)-1-Boc-3-氰基吡咯烷 | tert-butyl (R)-3-cyanopyrrolidine-1-carboxylate | 132945-76-7 | C10H16N2O2 |
|
(R)-1-Boc-2-氰基吡咯烷 | tert-butyl 2-cyanopyrrolidine-1-carboxylate | 144688-70-0 | C10H16N2O2 |
|
(R)-1-BOC-3-氟吡咯烷 | (R)-1-N-tert-butoxycarbonyl-3-fluoropyrrolidine | 876617-25-3 | C9H16FNO2 |
|
(R)-1-BOC-2-羟甲基哌嗪 | tert-butyl (R)-2-(hydroxymethyl)piperazine-1-carboxylate | 169448-87-7 | C10H20N2O3 |
|
(R)-1-(甲氧基(甲基)氨基)-1-氧代-2-丙基氨基甲酸叔丁酯 | tert-butyl N-[(1R)-2-[methoxy(methyl)amino]-1-methyl-2-oxo-ethyl]carbamate | 146553-06-2 | C10H20N2O4 |
|
(R)-1-(3-氯苯基)乙醇 | (R)-1-(3-chlorophenyl)-ethanol | 120121-01-9 | C8H9ClO |
|
(R)-1-(3-氯苯基)乙胺 | (R)-1-(3-chlorophenyl)ethanamine | 17061-53-9 | C8H10ClN |
|
(R)-1-(2-氟苯基)乙胺 | (R)-1-(2-fluorophenyl)ethan-1-amine | 185545-90-8 | C8H10FN |
|
(R)-1-(2,6-二氯-3-氟苯基)乙醇 | (R)-1-(2,6-dichloro-3-fluorophenyl)ethanol | 330156-50-8 | C8H7Cl2FO |
|
(R)-1,3-二甲基哌嗪-2-酮盐酸盐 | (R)-1,3-dimethylpiperazine-2-one hydrochloride | 1373232-29-1 | C6H12N2O*ClH |
|
(R)-1,2-二噻茂烷-3-戊酸钠 | sodium lipoic acid | 176110-81-9 | C8H13O2S2*Na |
|
(R)-(-)-8a-甲基-3,4,8,8a-四氢-1,6(2H,7H)-萘二酮 | (R)-Wieland-Miescher ketone | 100348-93-4 | C11H14O2 |
|
(R)-(-)-4-氨基-3-羟基丁酸 | (R)-4-Amino-3-hydroxybutanoic acid | 7013-07-2 | C4H9NO3 |
|
(R)-(-)-4-(3-吲哚氧基甲基)-2-恶唑烷酮 | 4-(1H,indol-3-ylmethyl)-2-oxazolidinone | 157636-81-2 | C12H12N2O2 |
|
(R)-(-)-3-氨基哌啶 二盐酸盐 | (R)-3-Aminopiperidine dihydrochloride | 334618-23-4 | C5H14Cl2N2 |
|
(R)-(-)-3-异丙基-2,5-哌嗪二酮 | (R)-3-isopropylpiperazine-2,5-dione | 143673-66-9 | C7H12N2O2 |
|
(R)-(-)-3-奎宁醇 | (R)-quinuclidin-3-ol | 25333-42-0 | C7H13NO |
|
(R)-(-)-3-(氨甲酰甲基)-5-甲基己酸 | (R)-(-)-3-(carbamoylmethyl)-5-methylhexanoic acid | 181289-33-8 | C9H17NO3 |
|
(R)-(-)-2-甲基戊二酸 | (R)-2-methylglutaric acid | 1115-81-7 | C6H10O4 |
|
(R)-(-)-2-甲基哌嗪 | (2R)-methylpiperazine | 75336-86-6 | C5H12N2 |
|
(R)-(-)-1-甲基-3-羟基吡咯烷 | (R)-1-methyl-3-pyrrolidinol | 104641-60-3 | C5H11NO |
|
(R)-(-)-1-氨基茚盐酸盐 | (R)-2,3-dihydro-1H-inden-1-amine hydrochloride | 10305-73-4 | C9H11N*ClH |
|
(R)-(+)-叔丁基亚磺酰胺 | (R)-2-methylpropane-2-sulfinamide | 196929-78-9 | C4H11NOS |
|
(R)-(+)-alpha-氨基-gamma-丁内酯盐酸盐 | (R)-α-amino-γ-butyrolactone hydrochloride | 104347-13-9 | C4H7NO2*ClH |
|
(R)-(+)-5’-甲氧基劳丹素 | 5'-methoxylaudanosine | 24734-71-2 | C22H29NO5 |
|